Fatty acids, IL6, and TNFα polymorphisms: An example of nutrigenetics in Crohn's disease

American Journal of Gastroenterology

Volumn 104, Issue 9, 2009, Pages 2241-2249

  Guerreiro, Catarina Sousa ^a,f   Ferreira, Paula ^b   Tavares, Lourdes ^c,g   Santos, Paula Moura ^c,h   Neves, Manuela ^d   Brito, Miguel ^b   Cravo, Marília ^e  

^a UNIVERSITY OF LISBON   (Portugal)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Escola Superior de Tecnologia da Sade de Lisboa   (Portugal)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e HOSPITAL DE SANTA MARIA   (Portugal)

^f INSTITUTO SUPERIOR DE AGRONOMIA   (Portugal)

^g EPE   (Portugal)

^h Escola Superior de Tecnologias e Saúde de Lisboa ESTeSL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; LYMPHOTOXIN; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE PREDISPOSITION; FAT INTAKE; FEMALE; GENE INTERACTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CROHN DISEASE; CYTOKINES; DIETARY FATS; FATTY ACIDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NUTRIGENOMICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69949187153     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.313     Document Type: Article

References (31)

1. Balding J, Livingstone W, Conroy J et al. Infl ammatory bowel disease: the role of infl ammatory cytokine gene polymorphisms. Mediators Infl amm 2004; 13: 181-7.
2. Koss K, Satsangi J, Fanning G et al. Cytokine (TNF-a, LT-a and IL-10) polymorphisms in infl ammatory bowel diseases and normal controls: diff erential eff ects on production and allele frequencies. Genes Immun 2000; 1: 185-90.
3. Sadeghi S, Wallace FA, Calder PC. Dietary lipids modify cytokine response to bacterial lipopolysasscharide in mice. Immunology 1999; 96: 404-10.
4. Grimble R, Howell W, Reilly G et al. Th e ability of fi sh oil to suppress tumour necrosis factor x production by peripheral blood monuclear cells in healthy men is associated with polymorphisms in genes that infl uence tumour necrosis factor - production. Am J Clin Nutr 2002; 76: 454-9.
5. Markovic O, O'Reilly G, Fussell H et al. Role of single nucleotide polymorphisms of pro-infl ammatory cytokine genes in the relationship between serum lipids and infl ammatory parameters, and the lipid-lowering eff ect of fi sh oil in healthy males. Clin Nutr 2004; 23: 1084-95.
6. Gassull MA, Fernandez-Banares F, Cabre E et al. Fat composition may be a clue to explain the primary therapeutic eff ect of enteral nutrition in Crohn's disease: results of a double blind randomized multicentre European trial. Gut 2002; 51: 164-8.
7. Baumgart D, Carding D. Infl ammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-40.
8. Satsangi J, Morecnoft J, Shah N et al. Genetics of infl ammatory bowel disease: scientifi c and clinical implications. Best Pract Res Clin Gastroenterol 2003; 17: 3-18.
9. Lennard Jones JE. Classifi cation of infl ammatory bowel disease. Scand J Gastroenterol 1989; 24 (Suppl): 2-6.
10. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 1: 514.
11. Lopes CM. Reprodutibilidade e valida ç ã o do question á rio semiquantitativo de frequ ê ncia alimentar. In Alimenta ç ã o e Enfarte agudo do mioc á rdio: Estudo de caso-controlo de base comunit á ria. Tese de doutoramento: Porto, 2000, pp. 78-115.
12. Sawczenko A, Azooz O, Paraszczuk J et al. Intestinal infl ammation-induced growth retardation acts throughIL-6 in rats and depends on 174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci USA 2005; 102: 13260-5.
13. Fishman D, Faulds G, Jeff ery R et al. Th e eff ect of novel polymorphisms in the interleukin (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-76.
14. Klein W, Tromm A, Griga T et al. Th e polymorphism at position-174 of the IL-6 gene is not associated with infl ammatory bowel disease. Eur J Gastroenterol Hepatol 2001; 13: 45-7.
15. Terry C, Loukaci A, Green F. Cooperative infl uence of genetic polymorphism on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275 (24): 18132-44.
16. Peeters EL, Franchimeont D, Seidel L et al. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): infl uence on disease behavior? Clin Exp Immunol 2000; 119: 64-8.
17. O' Morain C, Segal AW, Levi A. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J 1984; 288: 1859-84.
18. Fernandez-Banares F, Cabre E, Esteves-Comas M et al. How eff ective is enteral nutrition in inducing clinical remission in active Crohn's disease. A meta-analysis of randomized clinical trials. J Parenter Enteral Nutr 1995; 19: 356-63.
19. Griffiths AM, Ohlosson A, Sherman PM et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn disease. Gastroenterology 1995; 108: 1056-67.
20. Messori A, Trallori G, D Á lbasio G et al. Defi ned-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterology 1996; 31: 267-72.
21. Fernandez-Banares F, Cabr é E, Gonz á lez-Huix F et al. Enteral nutrition as primary therapy in Crohn's disease. Gut 1994; 25: SS55-9.
22. Middleton SJ, Rucker JT, Kirby GA. Long-chain triglycerides reduce the effi cacy of enteral feds in patients with active Crohn disease. Clin Nutr 1995; 14: 229-36.
23. Teitelbaum JE, Walker WA. Review: the role of omega 3 fatty acids in intestinal infl ammation. J Nutr Biochem 2001; 12: 21-32.
24. Shoda R, Metsueda K, Yamoto S et al. Epidemiologic analysis of Crohns disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohns disease in Japan. Am J Clin Nutr 1996; 63: 741-5.
25. Belluzzi A, Bringole C, Campieri M et al. Eff ects of an enteric coated fi sh oil preparation on relapse in Crohn disease. New Engl J Med 1996; 334: 1557-60.
26. Mac Lean CH, Mojica W, Newberry SJ et al. Systematic review of eff ects of n-3 fatty acids in infl ammatory bowel disease. Am J Clin Nutr 2005; 82: 611-9.
27. Mozaff arian D, Pischon T, Hankinson SE et al. Dietary intake of trans fatty acids and systemic infl ammation in women. Am J Clin Nutr 2004; 79: 606-12.
28. Pischon T, Hankinson SE, Hotamisligil GS et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to infl ammatory markers among US men and women. Circulation 2003; 108: 155-60.
29. Van Heel D, Udalova I, De Silva A. Infl ammatory bowel disease is associated with a TNF polymorphism that aff ects an interaction between the OCT1 and NF-KB transcription factors. Hum Mol Genet 2002; 11: 1281-9.
30. Tucker KL. Assessment of usual dietary intake in population studies of gene-diet interaction. Nutr Metab Cardiovasc Dis 2007; 17: 74-81.
31. Guerreiro CS, Cravo M, Costa AR et al. A comprehensive approach to evaluate nutritional status in Crohn's patients in the era of biologic therapy: a case-control study. Am J Gastroenterol 2007; 102: 2551-6.